Targeting redox-sensitive MBD2-NuRD condensate in cancer cells

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Transcriptional silencing of tumor suppressor genes via hypermethylation is a key event in cancer.
• The precise mechanisms driving this silencing remain largely unknown.

Purpose of the Study:

• To elucidate the role of methyl-CpG-binding domain protein 2 (MBD2) in transcriptional gene silencing during tumorigenesis.
• To investigate the potential of targeting MBD2 condensates for cancer therapy.

Main Methods:

• Utilized diverse cancer cell lines to study MBD2 condensate formation and function.
• Investigated the interaction between MBD2 and the NuRD complex.
• Assessed the impact of MBD2 condensate disruption on chromatin structure and gene expression.
• Examined the redox sensitivity of MBD2 condensates and the effect of pro-oxidative interventions.

Main Results:

• MBD2 forms nuclear condensates in cancer cells, recruiting the NuRD complex to silence tumor suppressor genes and promote tumor growth.
• Disrupting MBD2 condensates leads to reduced NuRD complex proteins, destabilized heterochromatin, and chromatin relaxation, thereby inhibiting tumor progression.
• MBD2 condensate formation is redox-sensitive, with pro-oxidative treatments dispersing condensates and alleviating gene repression.

Conclusions:

• MBD2 nuclear condensates play a critical role in maintaining the repressive chromatin state essential for cancer cell proliferation.
• Targeting MBD2 condensates via oxidative stress presents a potential therapeutic strategy for cancers characterized by excessive MBD2 condensate formation.